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ABSTRAK
Tujuan: untuk  mengidentifikasi faktor risiko kandidemia  dan mengembangkan sistem skoring kandidemia 
yang dapat digunakan di Rumah Sakit Cipto Mangunkusumo (RSCM), Jakarta, Indonesia. Metode: studi 
retrospektif dengan kasus kontrol dilakukan dengan menggunakan rekam medik pasien tahun 2011-2014. Semua 
pasien sepsis yang dirawat di RSCM dengan hasil kultur darah  positif Candida dimasukkan sebagai kelompok 
kasus. Kelompok kontrol yaitu semua pasien sepsis tanpa kandidemia. Perbandingan kelompok kasus dengan 
kontrol adalah sama (1:1). Hasil: dari 234 pasien yang dianalisis, faktor risiko yang bermakna pada penelitian 
ini yaitu lama perawatan 8-14 hari (OR 3,464; 95% CI 1,458-7,800), lama perawatan lebih dari 14 hari (OR 
6,844;  CI 3,0-15,330), sepsis berat (OR 16,407; 95% CI 1,458-7,800) dan pembedahan (OR 3,03; 95% CI 1,492-
6,152).  Prediktor kandidemia di RSCM yaitu lama perawatan 8-14 hari (nilai 1), lama perawatan lebih dari 14 
hari (nilai 2), sepsis berat (nilai 3) dan pembedahan (nilai 1) dengan nilai cut off 3,5. Kesimpulan: hasil studi 
ini mengindikasikan bahwa sistem skoring sebagai panduan terapi empirik kandidemia dapat dikembangkan 
dengan menggunakan faktor risiko kandidemia dari pasien yang diidentifikasi sebagai pasien berisiko di RSCM.
Kata kunci: kandidemia, faktor risiko, sistem skoring.
ABSTRACT
Aim: to identify the risk factors of candidemia and to develop a scoring system that could be implemented 
in Cipto Mangunkusumo Hospital (RSCM), Jakarta, Indonesia. Methods: this study was a retrospective study 
with case control design using the medical records of patients since 2011 to 2014. All sepsis patients hospitalized 
in the RSCM with a positive blood culture for Candida were included in this study as a case group. The control 
group was all of the sepsis patients without candidemia. The ratio for case and control groups was equal (1:1). 
Results: from 234 patients who were analyzed, the risk factors that influenced the study were length of stay 
of 8-14 days (OR 3.464; 95% CI 1.458-7.800), length of stay of more than 14 days (OR 6.844; 95% CI 3.0-
15.330), severe sepsis (OR 16.407; 95% CI 1.458-7.800), and surgery (OR 3.03; 95% CI 1.492-6.152). The 
predictors for candidemia in RSCM were length of stay in hospital for 8-14 days (score 1), a length of stay ≥14 
days (score 2), severe sepsis (score 3), and surgery (score 1), with a cut off score of 3.5. Conclusion: the results 
of this study have indicated that a scoring system in order to guide an empirical treatment for candidemia can 
be developed by using the risk factors for candidemia from patients who have been identified as patients with 
risk at Cipto Mangunkusumo Hospital.
Keywords: candidemia, risk factor, scoring system.
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INTRODUCTION
Candida species have become an important 
cause of nosocomial infections due to their 
potential cause of mortality and a prolonged 
hospitalization time.1 Candida is the fourth most 
common cause of nosocomial blood stream 
infections in the United States with a mortality 
rate of more than 40%, even though adequate 
antifungal therapy was given. The incidence of 
invasive candidiasis is various in countries and 
it ranges between 3.4% to  5.79%.2,3 There is 
a shifting of the causative agents for invasive 
candidiasis infections from Candida albicans to 
a non-albicans Candida species.3,4
An early identification of sepsis patients who 
have high risk for fungal infection is challenging, 
because of the complexity of a patient’s 
condition, a low rate of success, and a long 
period of time in order to obtain the results for 
fungal culture.5 It is important to develop a tool 
to predict high risk patients who might develop 
candidemia and need an empirical antifungal 
therapy. A prediction system of candidemia 
that was based on patient’s clinical status was 
developed by Paphitou6 and Ostrosky Zeichner.7 
In addition, a scoring system that is now called 
a “Candida Score” was also developed and was 
based upon some parameters.8 A limitation of 
the lack clinical prediction is the possibility 
of a massive antifungal therapy problem that 
can change a local epidemiological pattern in a 
hospital, as well as increasing the resistance to 
antifungals.6,9 This study aimed at identifying 
the risk factors of candidemia in RSCM hospital 
in Jakarta, Indonesia. It was conducted in order 
to develop a scoring system that is based upon 
the risk factors that have been identified for 
candidemia which can be implemented to predict 
the occurrence of candidemia.
METHODS
A retrospective case control study was 
conducted using the medical records of sepsis 
patients during the period of 2011 to 2014. All 
sepsis patients hospitalized in RSCM with a 
positive blood culture for Candida were included 
in the case study group. The control group were 
sepsis patients with a negative candidemia (a 
sterile culture or a bacterial growth). The ratio for 
case and control group was equal (1:1). For the 
control group, we matched the same age groups 
and the wards of the patients.
Quantitative data analyzes were presented as 
mean and standard deviations (SD) or as median 
with a maximum and minimum value. Frequency 
was used to describe the categorical data. To 
obtain the risk factors for candidemia, we 
performed bivariate analysis. The variables with 
significant risk factors (p<0.25) were included 
in multivariate and logistic regression models.
The accuracy of the scores was determined 
by a Receiver Operating Curve (ROC). The 
data was analyzed by using SPSS 11.5 software. 
An ethical clearance was obtained from the 
Ethical Committee at the Faculty of Medicine, 
University of Indonesia, Cipto Mangunkusumo 
Hospital, Jakarta, Indonesia (No. 742/UN2.FI/
ETIK/2O14).
RESULTS
A total of 234 sepsis patient’s data was 
obtained for this study. From that number, 117 
were sepsis patients with candidemia and the 
same amount was included as a control group. 
The patient’s data and bivariate analysis are 
presented in Table 1.
The results obtained have shown that the 
major age group of patients was 16 to 60 years 
(43.6%), of which 70% of them had severe sepsis 
and 77% had chronic diseases. The majority of 
the patients had neutrophils of more than 500 
(85%) and 52.1% of the patients had a normal 
monocyte count (2%-8%). From patients who 
were hospitalized in ICU and HCU (60.7%), the 
hospital length of stay was more than 14 days 
(43.2%) and the length of stay in ICU ranged 
between 1-7 days (68.3%). Most of patients 
had urinary catheter (86.3%), central venous 
catheter (53%) and had antimicrobial therapy 
administered for more than five days (77.8%). 
Most of the patients were treated with two 
antimicrobial regimens.
The bivariate analysis of the risk factors for 
candidemia showed that the variables associated 
with an increased risk of candidemia with 
p<0.25 were severe sepsis, neutrophil count 
<500, hospital length of stay of more than 7 
days, length of stay in ICU of more than 7 days, 
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urinary catheter, mechanical ventilator, central 
venous catheter, surgery, abdominal surgery, 
antimicrobial therapy >5 days, and a number of 
antimicrobials of 2 to more than 3.
The multivariate analysis for candidemia 
risk factors are shown in Table 2. It is shown 
that a length of stay of 8-14 days, a length of 
stay of more than 14 days, severe sepsis, and 
surgery, were associated with the development 
of candidemia.
To develop the scoring system, we used a 
logistic regression model, in order to predict the 
relationship between the independent variables 
that were obtained from the multivariate analysis, 
with a dependent binary variable (without 
candidemia or with candidemia). The results are 
shown in Table 3.
In the logistic regression analysis, the results 
showed that the probability of a patient having 
candidemia would be one time, if the length of 
Table 1. Variables associated with Candidemia
Risk Factor Total (N=234)n (%)
Sepsis with Candidemia
n (%)
Sepsis Without Candidemia
n (%)
Age
 - <1 year 27 (11.5) 13 (11.0) 14 (12.0)
 - 1-16 years 57 (24.4) 29 (25.0) 28 (24.0)
 - 16 to <60 year 102 (43.6) 51 (44.0) 51 (44.0)
 - ≥60 years 48 (20.5) 24 (21.0) 24 (21.0)
Severe Sepsis 162 (69.2) 106 (91.0) 56 (48.0)
Candida Colonization 56 (24.0) 29 (25.0) 27 (23.0)
Chronic Disease 156 (77.0) 77 (66.0) 79 (68.0)
Neutrophil Count
 - ≥500 199 (85.0) 94 (47.2) 105 (52.8.0)
 - <500 35 (15.0) 23 (20.0) 12 (10.0)
Monocyte Count 2-8% 122 (52.1) 61 (52.0) 61 (52.0)
 - >8 63 (26.5) 27 (23.0) 36 (31.0)
 - <2 49 (20.9) 29 (25.0) 20 (17.0)
Hospital Length of Stay
 - 1-7 days 71 (30.3) 17 (15.0) 54 (47.0)
 - 8-14 days 61 (26.1) 31 (27.0) 30 (26.0)
 - >14 days 101 (43.2) 69 (59.0) 32 (27.0)
Length of Stay in the ICU
 - 1-7 days 97 (68.3) 41 (73.0) 56 (87.0)
 - 8-14 days 29 (20.4) 18 (25.0) 11 (16.0)
 - >14 days 16 (11.3) 12 (17.0) 4 (6.0)
Urinary Catheter 202 (86.3) 109 (93.0) 93 (80.0)
Immunosuppression Drugs 20 (12) 14 (12.0) 6 (5.0)
Mechanical Ventilator 96 (41) 56 (48.0) 40 (34.0)
Central Venous Catheter 124 (53) 73 (62.0) 51 (44.0)
Surgery 110 (47) 67 (57.0) 43 (37.0)
Abdominal Surgery 65 (27.8) 46 (39.0) 19 (16.0)
Total Parenteral Nutrition 49 (21) 23 (20.0) 26 (22.0)
Antimicrobial >5 days 182 (77.8) 102 (87.0) 80 (68.0)
Number of Antimicrobials
 - 1 69 (29.5) 23 (27.0) 46 (34.0)
 - 2 72 (30.8) 32 (28.0) 40 (34.0)
 - 3 47 (20.1) 29 (25.0) 18 (15.0)
 - >3 43 (18.4) 32 (27.0) 11 (9.0)
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hospitalization of more than 14 days, a plus score 
of 3 for severe sepsis, a plus score of 1 for the 
surgery, a total score of 6.
The accuracy of the testing depends on how 
well the test distinguished the groups being 
tested, into those with and without the disease 
in question. The accuracy was measured by the 
area under the Receiver Operating Characteristic 
(ROC) curve. The ROC results are shown in 
Figure 1 and Table 4.
With the cut off value obtained was 3.5 with 
81% sensitivity and 72% specificity, the AUC 
was 0.838; 95% CI 0.79-0.89. This result meant 
that the accuracy of this scoring as diagnostic 
test was good. This also meant that these three 
variables (the length of the stay in the hospital, 
severe sepsis and surgery) were good mediators 
to differentiate the patients with candidemia or 
without candidemia.
To validate the candidemia scoring with a cut 
off value 3.5, the scoring was then tested with the 
study group and the control group. The results 
are shown in Table 5.
The results of the implementation of 
the scoring showed that the sensitivity was 
95/117=80%, the specificity was 84/117=70%, 
the Positive Predictive Value (PPV) was 
95/128=74% and the Negative Predictive Value 
(NPV) was 84/106=79%.
DISCUSSION
Candidemia is an uncommon case and it 
remains a significant concern for hospitalized 
patients, especially for those in the Intensive 
Care Units.10 Candidemia is mainly developed 
in critically ill patients with terminal disease 
and with co-existing multiple organ failures.11 
Table 2. Multivariate analysis of the variables associated 
with Candidemia
Risk Factor p value OR (95% CI)
Hospital Length of Stay
 - 1-7 days Ref
 - 8-14 days 0.004 3.464 (1.458-7.800)
 - >14 days 0.000 6.844 (3.00-15.330)
Length of Stay in the ICU
 - 1-7 days Ref
 - 8-14 days 0.516 0.687 (0.222-2.133)
 - >14 days 0.416 1.938 (0.394-9.545)
Urinary Catheter 0.104 2.954 (0.802-10.890)
Abdominal Surgery 0.095 2.641 (0.846-8.245)
Mechanical Ventilator 0.384 1.444 (0.631-3.302)
Central Venous 
Catheter
0.795 1.114 (0.492-2.525)
Immunosuppression 
Drugs
0.294 1.981 (0.553-7.102)
Antimicrobial >5 days 0.738 1.185 (0.439-3.200)
Number of Antimicrobials
 - 1 Ref
 - 2 0.580 1.289 (0.524-3.171)
 - 3 0.859 0.910 (0.322-2.571)
 - >3 0.499 1.562 (0.429-5.694)
Severe Sepsis 0.000 16.407 (1.458-7.800)
Surgery 0.002 3.030 (1.492-6.152)
Neutrophils <500 0.066 2.729 (0.935-7.967)
Table 3. The calculation of the scores: variables that were selected by the logistic regression model for Candidemia in the 
hospital
Variables Coefficient (β) Standard Error  Wald  X2 P value
Length of Stay 8-14 
days
1.263 0.431 8.598 0.003
Length of Stay>14 
days
1.932 0.412 21.951 0.000
Surgery 0.790 0.362 9.161 0.002
Severe Sepsis 2.819 0.431 42.880 0.000
Constant -3.726 0.533 48.886 0.000
stay was between 8-14 days (score 1). It would be 
twice when the length of stay was more than 14 
days (score 2). The score is added one time if they 
had surgery (score 1), and added 3 times if they 
had severe sepsis (score 3). The implementation 
of this scoring is, as follows: when patients were 
hospitalized for 16 days with severe sepsis and 
had surgery, they would have a score of 2 for a 
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Zaoutis et al.14 Surgery, especially abdominal 
surgery, caused an interruption in the integrity 
of the gastrointestinal tract mucous that caused 
a port of entry for the Candida to pass from the 
lumen to the bloodstream.15
Furthermore, this study has the same results 
as the study of Leon et al.8 who developed the 
Candida Score. In fact, the score system that 
we have developed offers several advantages 
over the Candida Score. Two variables of the 
Candida Score (severe sepsis and surgery) are 
used at our hospital. For an addition, one new 
variable, which was the hospital length of stay, 
was identified. This new scoring system is easy 
to remember, since it is only has a few variables, 
including severe sepsis and surgery. This type 
of scoring does not need to include a laboratory 
examination (i.e., a culture to confirm Candida 
colonization). This has not been routinely 
conducted in our hospital, because it is costly 
and labor extensive.16 The sensitivity and the 
specificity of this new scoring are proposed to 
Table 4. Cut-off value for the ROC curve for the 
Candidemia scoring system in the hospital
Cut-off value Sensitivity False positive
-1.0 1.0 1.0
0.5 1.0 0.880
1.5 0.991 0.675
2.5 0.974 0.581
3.5 0.812 0.282
4.5 0.624 0.145
5.5 0.333 0.042
7.0 0.000 0.000
The age range of the patients in this study had 
the same results as Wu et al.12 in which the 
patients ages were 1-88 years with a median 
of 40 years. In this study, 77% of the patients 
had chronic diseases. The presence of a chronic 
disease was important as a risk factor and in the 
management of the patients. This was because 
the drug interactions for antifungal should 
be considered in those patients with diabetes 
mellitus or tuberculosis, who have had therapy 
for their concomitant diseases.13
In the multivariate analysis, the hospital 
length of stay, severe sepsis and surgery, were 
associated with candidemia. Several other 
risk factors that have been associated with 
candidemia in other studies were not associated 
with candidemia in the present study. In this 
study, candidemia was associated with a longer 
hospital stay, which is similar to the study of 
AUC 0.838
95% CI 0.788-0.888
Figure 1. Receiver operating characteristic (ROC) curve and the area under the curve (AUC) power 
to assess the scores
Table 5. The scoring system with a cut-off of 3.5 when 
tested with the study group and the control group
Score
Sepsis with 
Candidemia
n (%)
Sepsis without  
Candidemia
n (%)
Total
>3.5 95 (80.0) 33 (30.0) 128
<3.5 22 (20.0) 84 (70.0) 106
Total 117 117 234
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be used for screening the patients who need 
antifungal therapy and can minimize any 
unnecessary treatment.
The scoring system obtained in this study 
might be implemented in RSCM, rather than 
Candida score, but it requires further validation. 
The validation should be performed in a 
prospective study, with a selected ward, or in 
two different hospitals, as in the Michalopoulos 
study.17
The limitation of this study is sample 
size. The sample size was quite small because 
candidemia is rare and the culture does not 
always available. Since the data were from one 
center, it needs careful, interpretation if the 
results were to be implemented in other centers. 
The calculations for the scoring were from 
secondary data, so the scores that were obtained 
were not as accurate as the patient’s condition at 
the time. The strength of the study was the case 
control study design that could analyze important 
variables in a Candida infection.
It is necessary to record data and evaluate 
the health care-associated infection, especially 
Candidemia, in all of the wards at a hospital, so that 
prevention can be instigated. The implementation 
of a scoring system is important for the reasons to 
start an empiric antifungal therapy.
CONCLUSION
The significant risk factors associated with 
candidemia in this study were the hospital length 
of stay, severe sepsis and surgery. The new 
scoring system that has been developed can be 
implemented in order to predict those patients that 
might result in a possible candidemia condition, 
by following these criteria: a hospital stay of 8-14 
days (score 1), a hospital stay of more than 14 
days (score 2), severe sepsis (score 3) and surgery 
(score 1), with a cutoff value of 3.5.
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